Plus Therapeutics Announces Encouraging Clinical Trial Outcomes at the 2024 SNO/ASCO CNS Metastases Conference.
Clinical-stage Therapeutics Company Presents Positive Clinical Trial Results
Clinical-stage Therapeutics Company Presents…
Clinical-stage Therapeutics Company Presents Positive Clinical Trial Results
Plus Therapeutics Announces Encouraging Clinical Trial Outcomes at the 2024 SNO/ASCO CNS Metastases Conference.